NCCN 2019 Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™

Orlando, FL US
March 21, 2019 to March 23, 2019

The NCCN 2019 Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ attracts more than 1,600 registrants from across the United States and the globe including oncologists (in both community and academic settings), oncology fellows, nurses, pharmacists, and other health care professionals involved in the care of patients with cancer. Respected opinion leaders present the latest cancer therapies and provide updates on selected NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), the data upon which the NCCN Guidelines® are based, and quality initiatives in oncology. Topics change annually but focus on the major cancers and supportive care areas.

Agenda

Fees

Target Audience

This educational program is designed to meet the educational needs of the interprofessional oncology care team, including: physicians/oncologists, nurses, physician assistants, pharmacists, and other healthcare professionals who manage patients with cancer.

Learning Objectives

Following this program, participants should be able to:

  • Summarize the current standards of oncology care and key updates in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and as appropriate integrate these strategies into the management of patients with: bladder cancer, breast cancer, chronic myeloid leukemia, central nervous system cancers, colon/rectal cancer, ovarian cancer, kidney cancer, lung cancer, melanoma, neuroendocrine tumors, pancreatic cancer, and sarcomas.
  • Evaluate new, emerging and novel therapeutic agents, advances in care, and clinical trials data and apply relevant findings into the management of patients with cancer.
  • Review supportive care issues affecting the management of patients with cancer to improve patient outcomes.
  • Discuss the changes and challenges affecting staging of multiple cancers using the 8th Edition of the AJCC Staging Manual.

A detailed list of learning objectives by session topic is available here.

Additional information
Supporters: 

This activity is supported by educational grants from:

  • AstraZeneca
  • Bayer HealthCare Pharmaceutials, Inc.
  • BTG
  • Celgene Corporation
  • Daiichi Sankyo, Inc.
  • Genentech
  • Genomic Health, Inc.
  • Halozyme, Inc.
  • Ipsen Biopharmaceuticals
  • Lilly
  • Novartis
  • Pfizer
  • Prometheus Laboratories, Inc.
  • Puma Biotechnology
  • Taiho Oncology, Inc.
  • TESARO

This activity is supported by educational funding provided by:

  • Amgen

This activity is supported by independent educational grants from:

  • AbbVie
  • Astellas
  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Incyte
  • Merck & Co., Inc.

This activity is supported by a medical education grant from:

  • Exelixis, Inc.

 

Course summary
Available credit: 
  • 17.75 AAPA Category 1 CME credit
  • 17.75 ABIM MOC
  • 17.75 AMA PRA Category 1 Credit™
  • 17.75 ANCC contact hours
  • 17.75 CCM clock hours
  • 17.75 Participation
  • 17.50 NCRA CE hours
  • 13.00 Category A
Course opens: 
03/21/2019
Course expires: 
06/30/2022
Event starts: 
03/21/2019 - 8:00am EDT
Event ends: 
03/23/2019 - 3:30pm EDT
Cost:
$0.00
Rosen Shingle Creek
9939 Universal Boulevard
Orlando, FL 32819
United States

NCCN Medical Education Disclosure Policy

It is the policy of NCCN that every 12 months, all faculty, moderators, activity planners and all internal planning staff participating in NCCN continuing education activities are expected to disclose any financial relationships with a commercial interest as defined by the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support. In addition, all faculty presentations have been reviewed for adherence to the ACCME’s Standards for Commercial Support (the provider develops activities/educational interventions independent of commercial interests [SCS 1, 2 and 6] by experts on the topics). Full disclosure of faculty relationships will be made prior to the activity.

Per the ACCME Standards for Commercial Support, individuals who do not disclose relevant financial relationships will be disqualified from involvement in the CE activity as a content developer, planner, or presenter. A complete list of individuals’ relationships with external entities is available upon request.

Definitions  

NCCN continuing education considers financial relationships to create a “conflict of interest” when an individual has both a financial relationship with a commercial interest and the opportunity to affect CE content about the products or services of a commercial interest with which he/she and/or a spouse or partner has a financial relationship.

NCCN continuing education considers “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest. NCCN does not set a minimal dollar amount for relationships to be significant. Inherent in any amount is the incentive to maintain or increase the value of the relationship.

Faculty Disclaimers  

All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation for the tasks and methods of delivery.

Faculty presentations may include discussion of off-label use. Faculty will disclose that the use in question is not currently approved by the FDA per the product labeling.

In support of improving patient care, National Comprehensive Cancer Network (NCCN) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
NCCN designates this live activity for a maximum of 17.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
NCCN designates this educational activity for a maximum of 17.75 contact hours.

Pharmacists
NCCN designates this knowledge-based continuing education activity for 17.75 contact hours (1.775 CEUs) of continuing education credit. UAN: JA4008196-0000-19-001-L01-P

Physician Assistants
NCCN has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 17.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

American Board of Internal Medicine Maintenance of Certification


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 17.75 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.

Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Aggregated participant data will be shared with the commercial supporters of this activity.

American Board of Pathology Maintenance of Certification


This activity has been registered to offer credit in the American Board of Pathology’s (ABPath) Maintenance of Certification program. Participants may earn up to 17.75 Lifelong Learning (Part II) credits.

Aggregated participant data will be shared with the commercial supporters of this activity.

American Board of Medical Specialties Maintenance of Certification
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Maintenance of Certification (“MOC”) Activities through the ABMS Continuing Certification Directory, the NCCN 2019 Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) by the following ABMS Member Boards:

MOC Part II CME Activity
Anesthesiology
Family Medicine
Physical Medicine and Rehabilitation
Psychiatry & Neurology
Radiology
Urology

Case Managers
This program has been pre-approved by The Commission for Case Manager Certification to provide continuing education credit to CCM® board certified case managers. The course is approved for 17.75 CE contact hours.
Activity Code: C00035968
Approval Number: 190000495

Tumor Registrars
This program supports 17.5 CE hours of which 13 CE hours meet the Category A requirement and has been assigned the following event number: 2019-011

Available Credit

  • 17.75 AAPA Category 1 CME credit
  • 17.75 ABIM MOC
  • 17.75 AMA PRA Category 1 Credit™
  • 17.75 ANCC contact hours
  • 17.75 CCM clock hours
  • 17.75 Participation
  • 17.50 NCRA CE hours
  • 13.00 Category A

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection
  • Adobe Reader or other PDF reader software for certificate viewing/printing